Growth through Innovation and Service

Medicure is a value-based pharmaceutical company committed to the development and commercialization of innovative and affordable therapeutics for the U.S. market.

Our vision is to become a leading pharmaceutical company within the U.S., offering a growing portfolio of products that improve patients' lives.

Learn More

Our mission is to serve patients by delivering safe and efficacious life-changing medicines.

At Medicure, we are focused on improving the health of patients by offering a growing portfolio of products and services and ensuring all patients get access to care they need.

Our Products

Press Releases

MEDICURE ANNOUNCES RESIGNATION OF BOARD MEMBER AND GRANT OF STOCK OPTIONS

February 1, 2023

MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2022

November 24, 2022

MEDICURE TO PRESENT FINANCIAL RESULTS ON NOVEMBER 25, 2022 CALL at 8:30 AM ET FOR QUARTER ENDED SEPTEMBER 30, 2022

November 17, 2022

More Press Releases

Interview on Medicure's 25th Anniversary with CEO, Dr. Albert Friesen

Read More
2022 Third Quarter Results Announcement

We announced our third quarter 2022 results for the period which ended 30 September 2022 on Friday 25 November 2022.

Learn More
Our Mission

A Heart For Life

At Medicure, our mission is to serve patients by delivering safe and efficacious life-changing medicines

Learn More
Medicure Launches E-Commerce Pharmacy Platform Through its Subsidiary Marley Drug Pharmacy

Medicure Inc.– via Marley Drug, creates a direct-to-consumer e-commerce pharmacy solution. The service is available in all 50 states and can fulfill a formulary of over 100 prescription medications.

Learn More
Research and Products

Phase 3 clinical trial evaluating MC-1 for treatment of pyridoxal 5'-phosphate-dependent epilepsy

Medicure has filed with the FDA an IND for the use of MC-1 as a novel treatment for seizures associated with pyridox(am)ine 5'-phosphate oxidase (PNPO) deficiency.

Learn More
Lipid management is important for heart health

At Medicure, we are focused on improving the heart health of patients by delivering safe and efficacious cardiovascular medicines and ensuring all patients get access to therapy.

Learn More
News and Media

Antiplatelet therapy in the management of stroke patients

Medicure Announces Early Completion of Enrollment for iSPASM, a Phase 1/2a Exploratory Clinical Trial in Patients with Aneurysmal Subarachnoid Hemorrhage

Learn More

Stay Connected

Sign up for our newsletter

#PageBgImage{opacity:0}.fancybox-custom .fancybox-skin{box-shadow:0 0 50px #222}.fancybox-nav{width:60px}.fancybox-nav span{visibility:visible;opacity:1}.fancybox-nav:hover span{opacity:.7}.fancybox-next{right:-80px}.fancybox-prev{left:-80px}html{scroll-behavior:smooth}.bg-padding-top{padding-top:100px!important}.content_container_external_home_mobile.bg-padding-top,.content_container_external_mobile.bg-padding-top,.content_container_external_home_mobile .bg-padding-top,.content_container_external_mobile .bg-padding-top{padding-top:50px!important}.content_container_external_home .content_full .narrow_content iframe.youtube_embed,.content_container_external .content_full .narrow_content iframe.youtube_embed{height: calc(720px * 9 / 16) !important}.content_container_external_home .content_full .tile_size_75 iframe.youtube_embed,.content_container_external .content_full .tile_size_75 iframe.youtube_embed{height: calc(860px * 9 / 16) !important}.content_container_external_home .content_full .tile_size_66 iframe.youtube_embed,.content_container_external .content_full .tile_size_66 iframe.youtube_embed{height: calc(780px * 9 / 16) !important}.content_container_external_home .content_full .tile_size_50 iframe.youtube_embed,.content_container_external .content_full .tile_size_50 iframe.youtube_embed{height: calc(550px * 9 / 16) !important}.content_container_external_home .content_full .tile_size_33 iframe.youtube_embed,.content_container_external .content_full .tile_size_33 iframe.youtube_embed{height: calc(360px * 9 / 16) !important}.content_container_external_home .content_full .tile_size_25 iframe.youtube_embed,.content_container_external .content_full .tile_size_25 iframe.youtube_embed{height: calc(237px * 9 / 16) !important}.content_container_external_home .content_full .tile_size_20 iframe.youtube_embed,.content_container_external .content_full .tile_size_20 iframe.youtube_embed{height: calc(224px * 9 / 16) !important}.content_container_external_home .content_full .narrow_content iframe.youtube_embed,.content_container_external .content_full .narrow_content iframe.youtube_embed{height: calc(720px * 9 / 16) !important}#PageBgImage{opacity:0;transition:opacity 200ms;-moz-transition:opacity 200ms;-webkit-transition:opacity 200ms;-o-transition:opacity 200ms}.banner .banner_overlay .more>a{pointer-events:all}#bannerRotator ul li{-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover}#header_container,.banner{height:0;transition:height 200ms;-moz-transition:height 200ms;-webkit-transition:height 200ms;-o-transition:height 200ms}#content_container{margin-top:0;transition:margin 200ms;-moz-transition:margin 200ms;-webkit-transition:margin 200ms;-o-transition:margin 200ms}

Growth through Innovation and Service

Medicure is a value-based pharmaceutical company committed to the development and commercialization of innovative and affordable therapeutics for the U.S. market.

Our mission is to serve patients by delivering safe and efficacious life-changing medicines.

Press Releases

MEDICURE ANNOUNCES RESIGNATION OF BOARD MEMBER AND GRANT OF STOCK OPTIONS

MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2022

MEDICURE TO PRESENT FINANCIAL RESULTS ON NOVEMBER 25, 2022 CALL at 8:30 AM ET FOR QUARTER ENDED SEPTEMBER 30, 2022

Interview on Medicure's 25th Anniversary with CEO, Dr. Albert Friesen

2022 Third Quarter Results Announcement

Our Mission

A Heart For Life

Medicure Launches E-Commerce Pharmacy Platform Through its Subsidiary Marley Drug Pharmacy

Research and Products

Phase 3 clinical trial evaluating MC-1 for treatment of pyridoxal 5'-phosphate-dependent epilepsy

Lipid management is important for heart health

News and Media

Antiplatelet therapy in the management of stroke patients

Stay Connected

Sign up for our newsletter

About

Products

News and Media

Investors

Online Pharmacy

Contact Us